Epidermal growth factor receptor inhibitors in development for the treatment of non-small cell lung cancer.
about
Intratumoral epiregulin is a marker of advanced disease in non-small cell lung cancer patients and confers invasive properties on EGFR-mutant cellsApatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transportersTen things you should know about protein kinases: IUPHAR Review 14Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.Vandetanib (Zactima, ZD6474) antagonizes ABCC1- and ABCG2-mediated multidrug resistance by inhibition of their transport functionLapatinib-binding protein kinases in the African trypanosome: identification of cellular targets for kinase-directed chemical scaffoldsEGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage.Current situation of Panitumumab, Matuzumab, Nimotuzumab and Zalutumumab.Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitorsThe stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cellsPeptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapyFab-based bispecific antibody formats with robust biophysical properties and biological activityVandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis.Inhibiting kinases in malignant gliomas.Emerging drugs for non-small-cell lung cancer.A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments.Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.Perspectives for the use of structural information and chemical genetics to develop inhibitors of Janus kinasesCurrent vaccine updates for lung cancer.Emerging therapies: angiogenesis inhibitors for ovarian cancer.Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma lines.The anti-proliferative side effects of AEE788, a tyrosine kinase inhibitor blocking both EGF- and VEGF-receptor, are liver-size-dependent after partial hepatectomy in rats.Kinase-targeted cancer therapies: progress, challenges and future directions.
P2860
Q24603941-FBBAECF5-8EC9-4ACC-9AC2-D21CFD003D56Q24617999-71E5F636-34A2-4CBD-8C17-8AB53E304DF0Q26849417-154D4A6E-6A44-4E23-B5ED-D8322AEB7379Q27851483-2633D025-6F16-4947-B93A-68D915409DE5Q28475378-BD8DBE16-519D-41EB-B2EB-1253B53C2D1CQ28486270-77456F62-8F2A-4152-BE12-753B95EEC7E7Q34050547-3A042031-2E60-4E9F-8A1A-E8455ED32C13Q34586272-CCD7E57E-1B68-4116-8210-B630D3253AE8Q35116206-1AD19C7D-5F86-4AD4-9B3A-A30B0DA0BAF9Q35126922-01A93CA0-8F93-4628-98AC-C8150214B180Q36116250-6CDDA146-9295-4B67-AADF-363A1171A5CDQ36213193-EA6B62F2-68CC-49FB-B600-5B7A56CBFAAAQ36715777-4FAA07F2-7B03-493F-B791-440CD5DCDC32Q36764876-BC603B29-812A-4C94-998A-3562593AACE2Q36944026-B5C0146E-CE86-49A7-98F6-FCFAFBCEECB4Q37483162-29799D0A-F6DF-4D14-93FF-5F5177C6FC33Q37655607-635E27FC-9E1F-4809-9FD7-1181D134EFB2Q37687519-A51D370C-F80E-4E37-9CE1-3EB29BD4D58AQ37706593-EB075F92-E5E1-4E9A-A9C4-7777579007E2Q38497958-7DD1EE3B-2808-4786-AFFE-33F348BB747EQ39894634-E3451ED4-5B60-4D87-9157-BE0C57BCF951Q47445868-5ECFB2F2-22D5-4F1B-8458-2F8E572D4E22Q49887882-21D8975A-EFF1-466D-911E-FB0EC07C1BD3
P2860
Epidermal growth factor receptor inhibitors in development for the treatment of non-small cell lung cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Epidermal growth factor recept ...... of non-small cell lung cancer.
@ast
Epidermal growth factor recept ...... of non-small cell lung cancer.
@en
type
label
Epidermal growth factor recept ...... of non-small cell lung cancer.
@ast
Epidermal growth factor recept ...... of non-small cell lung cancer.
@en
prefLabel
Epidermal growth factor recept ...... of non-small cell lung cancer.
@ast
Epidermal growth factor recept ...... of non-small cell lung cancer.
@en
P50
P1476
Epidermal growth factor recept ...... of non-small cell lung cancer.
@en
P2093
Monique Nilsson
P304
4441s-4445s
P356
10.1158/1078-0432.CCR-06-0286
P407
P433
P577
2006-07-01T00:00:00Z